Evidence map›Paper›PMID 25890422›Full record

ArticleLancet (London, England)2015

Thrombolysis in acute stroke--authors' reply.

Jonathan Emberson, Kennedy R Lees, Patrick Lyden, Colin Baigent, Peter Sandercock, Werner Hacke, Stroke Treatment Trialists' Collaboration

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Neuroimaging evolution of ischemia in men and women: an observational study.Annals of clinical and translational neurology · 2019
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jonathan EmbersonClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Kennedy R LeesUniversity of Glasgow, Glasgow, UK.
Patrick LydenDepartment of Neurology, Cedars-Sinai, Los Angeles, CA, USA.
Colin BaigentClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: colin.baigent@ctsu.ox.ac.uk.
Peter SandercockUniversity of Edinburgh, Edinburgh, UK.
Werner HackeUniversity of Heidelberg, Heidelberg, Germany.
Stroke Treatment Trialists' Collaboration

Funding

Medical Research Council MC_U137686849
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleFibrinolytic AgentsHumansMaleStrokeTissue Plasminogen ActivatorFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID25890422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.